Monopar Therapeutics (NASDAQ:MNPR) Given “Hold” Rating at Jones Trading
Monopar Therapeutics (NASDAQ:MNPR – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Jones Trading in a research note issued on Wednesday,Benzinga reports. A number of other research firms have also weighed in on MNPR. HC Wainwright reiterated a “buy” rating and issued a $40.00 price objective on shares of Monopar […]
Monopar Therapeutics (NASDAQ:MNPR – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Jones Trading in a research note issued on Wednesday,Benzinga reports. A number of other research firms have also weighed in on MNPR. HC Wainwright reiterated a “buy” rating and issued a $40.00 price objective on shares of Monopar […]
